Osteopenia Suspended Phase 2 Trials for Testosterone (DB00624)

Also known as: Osteopaenia / Bone loss

IndicationStatusPhase
DBCOND0015922 (Osteopenia)Suspended2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01460654Testosterone and Alendronate in Hypogonadal MenTreatment